The IUB® SEAD® is an innovative intrauterine drug delivery technology for women with abnormal uterine bleeding and/or heavy menstrual bleeding. The current standard of care (global endometrial ablation) is considered invasive, burdensome, debilitating, and costly and may result in uterine wall adhesions and even a hysterectomy.
Current global ablation technologies currently in use require expensive capital equipment, extensive physician training, general anesthesia & hospitalization and cause high indirect costs and usually pain to women.
The IUB® SEAD® is a market game-changer through simplicity, cost-effectiveness, and new and innovative yet gentle “substance-derived ablation” technology. The IUB® SEAD® is nearly pain-free2 and efficacious to reduce bleeding and increase the quality of life.